Step by Stepa HemeOncBuddy patient portal

Lorlatinib

Illustration: Lorlatinib

Say it: lor-LA-tih-nib · Brand names: Lorbrena

Lorlatinib is a targeted pill that blocks a growth signal in lung cancers with a change in the ALK gene.

What it is

Some lung cancers have a change in a gene called ALK. Lorlatinib blocks the ALK signal, even in some cancers that stopped responding to other ALK pills. It also reaches the brain well.

Often used for

How you get it

It is a pill you take by mouth once a day, with or without food. People usually take it for as long as it works and side effects are OK. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Lorlatinib?
Lorlatinib is a targeted pill that blocks a growth signal in lung cancers with a change in the ALK gene. Brand names: Lorbrena.
What is Lorlatinib used for?
non-small cell lung cancer with an ALK gene change.
How is Lorlatinib given?
It is a pill you take by mouth once a day, with or without food. People usually take it for as long as it works and side effects are OK. Your schedule may be different.
What are the common side effects of Lorlatinib?
High cholesterol and fats in the blood. Swelling in the legs, feet, or hands. Numbness, tingling, or pain in the hands or feet. Changes in mood, memory, or thinking, or trouble sleeping. Weight gain. Feeling tired. Joint pain or diarrhea.
When should I call my care team while taking Lorlatinib?
Confusion, feeling very sad or anxious, seeing or hearing things that are not there, or changes in speech; Thoughts of hurting yourself; Slow heartbeat, dizziness, or fainting; New or worse cough, shortness of breath, or chest pain; Bad headache, or blood pressure higher than your team told you to expect; Feeling very thirsty, peeing a lot, or other signs of high blood sugar.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.